Boehringer Ingelheim Announces Growth for Financial Year 2012

News   Apr 30, 2013

 
Boehringer Ingelheim Announces Growth for Financial Year 2012
 
 
 

RELATED ARTICLES

Medicinal Compound in Plant Roots Examined

News

A New Phytologist study sheds light on the sites of synthesis and accumulation of xanthones in roots. The findings may be helpful for understanding the biosynthesis of xanthones and in efforts to manipulate them for medicinal purposes.

READ MORE

Tapeworm Drug Molecule Could Aid Fight Against Parkinson’s Disease

News

Researchers have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson's disease.

READ MORE

BioGenes Establishes Scientific Advisory Board

News

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, announces the establishment of a Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE